DNMT3A and periodontitis: For example, when adjusted for age and sex, the prevalence of stage IV periodontitis in carriers with DNMT3A mutations was (average marginal effect [AME]) 11 percentage points (95% confidence interval [CI] = 0.0–21.5) higher than in those without CHIP (Table S3).